Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct

Neuropathology

Volumn 33, Issue 2, 2013, Pages 140-148

  Kawabori, Masahito ^a   Kuroda, Satoshi ^a   Ito, Masaki ^a   Shichinohe, Hideo ^a   Houkin, Kiyohiro ^a   Kuge, Yuji ^b   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bone marrow stromal cell; Cerebral infarct; Dose; Timing; Transplantation

Indexed keywords

QUANTUM DOT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW STROMAL CELL TRANSPLANTATION; BRAIN ISCHEMIA; CELL FATE; CELL LABELING; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; ENGRAFTMENT; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT; TIME TO TREATMENT;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECOVERY OF FUNCTION; STEREOTAXIC TECHNIQUES; TIME FACTORS;

EID: 84875813306     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01335.x     Document Type: Article

References (34)

1. Chopp M, Steinberg GK, Kondziolka D etal. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant 2009; 18: 691-693.
2. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011; 42: 825-829.
3. Hokari M, Kuroda S, Shichinohe H, Yano S, Hida K, Iwasaki Y. Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. J Neurosci Res 2008; 86: 1024-1035.
4. Shichinohe H, Kuroda S, Tsuji S etal. Bone marrow stromal cells promote neurite extension in organotypic spinal cord slice: significance for cell transplantation therapy. Neurorehabil Neural Repair 2008; 22: 447-457.
5. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-882.
6. Honmou O, Houkin K, Matsunaga T etal. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011; 134: 1790-1807.
7. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010; 28: 1099-1106.
8. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother 2008; 8: 1193-1201.
9. Borlongan CV, Chopp M, Steinberg GK etal. Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med 2008; 3: 249-250.
10. Kuroda S. How should we bridge the missing steps in translational research for stroke therapy? - A critical review. Jpn J Stroke 2008; 30: 875-880.
11. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 2009; 16: 12-20.
12. Kuroda S, Shichinohe H, Houkin K, Iwasaki Y. Autologous bone marrow stromal cell transplantation for central nervous system disorders - recent progress and perspective for clinical application. J Stem Cell Regen Med 2011; 7: 1-12.
13. Ito M, Kuroda S, Sugiyama T etal. Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats - a serial MRI study. Transl Stroke Res 2011; 2: 294-306.
14. Sugiyama T, Kuroda S, Osanai T etal. Near-infrared fluorescence labeling allows noninvasive tracking of bone marrow stromal cells transplanted into rat infarct brain. Neurosurgery 2011; 68: 1036-1047 discussion 1047.
15. Kawabori M, Kuroda S, Sugiyama T etal. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology 2012; 32: 217-226.
16. Sugiyama T, Kuroda S, Takeda Y etal. Therapeutic impact of human bone marrow stromal cells expanded by animal serum-free medium for cerebral infarct in rats. Neurosurgery 2011; 68: 1733-1742.
17. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476.
18. Osanai T, Kuroda S, Sugiyama T etal. Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats - in vivo cell tracking study by near-infrared fluorescence imaging. Neurosurgery 2011; 70: 435-444.
19. Lee JB, Kuroda S, Shichinohe H etal. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 2003; 23: 169-180.
20. Lee JB, Kuroda S, Shichinohe H etal. A pre-clinical assessment model of rat autogeneic bone marrow stromal cell transplantation into the central nervous system. Brain Res Brain Res Protoc 2004; 14: 37-44.
21. Shichinohe H, Kuroda S, Lee JB etal. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res Brain Res Protoc 2004; 13: 166-175.
22. Yano S, Kuroda S, Shichinohe H, Hida K, Iwasaki Y. Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? - a double labeling study. Brain Res 2005; 1065: 60-67.
23. Shichinohe H, Kuroda S, Yano S, Hida K, Iwasaki Y. Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res 2007; 1183: 138-147.
24. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab 2012; Jan 18 [Epub ahead of print].
25. Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol 2007; 61: 396-402.
26. Chiba Y, Kuroda S, Osanai T, Shichinohe H, Houkin K, Iwasaki Y. Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF). Neuropathology 2012; 32: 139-148.
27. Saporta S, Borlongan CV, Sanberg PR. Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 1999; 91: 519-525.
28. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair 2009; 23: 895-909.
29. Darsalia V, Allison SJ, Cusulin C etal. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2010; 31: 235-242.
30. Sanchez-Ramos J, Song S, Cardozo-Pelaez F etal. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247-256.
31. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-370.
32. Yamaguchi S, Kuroda S, Kobayashi H etal. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC) - a preliminary study using microarray analysis. Brain Res 2006; 1087: 15-27.
33. Kamei N, Tanaka N, Oishi Y etal. Bone marrow stromal cells promoting corticospinal axon growth through the release of humoral factors in organotypic cocultures in neonatal rats. J Neurosurg Spine 2007; 6: 412-419.
34. The STEPS Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009; 40: 510-515.